Recombinant human serum albumin (OsrHSA) has emerged as a big innovation in the field of biopharmaceuticals, giving promising advancements throughout a variety of healthcare and industrial purposes. With its structural similarity to Normally derived human serum albumin, OsrHSA offers a safer, more dependable alternate for therapeutic use, specially